Categories

Cancer Care (276) I-CARE Early Covid (187) I-CARE Flu and RSV (36) I-PREVENT (153) I-RECOVER Long Covid (111) I-RECOVER Post-Vaccine (320) MATH+ (288)

Tags

ACE2 protein (10) acute respiratory distress syndrome (21) Anti-inflammatory (10) Antidepressants (9) Ascorbic Acid (12) autoantibodies (10) autophagy (24) Breast Cancer (14) Cancer (67) Chest CT (8) Corticosteroids (9) COVID-19 (329) COVID-19 Vaccines (8) Curcumin (8) Cytokines (13) Depression (11) Famotidine (14) Glucocorticoids (7) Hydroxychloroquine (12) Hyperbaric Oxygen Therapy (9) Inflammation (15) ivermectin (50) long COVID (21) Macrophages (18) Mast Cells (8) Melatonin (23) Mitochondria (14) Myeloid Cells (10) Non-Invasive Brain Stimulation (8) Omicron (7) Oxytocin (8) Pneumonia (9) quercetin (15) SARS-CoV-2 (83) SARS-CoV-2 mRNA Vaccines (8) Sepsis (20) spermidine (11) Spike Protein (12) Thiamine (10) Thrombosis (9) Tinnitus (12) Tumor (40) Vitamin C (30) Vitamin D (15) Zinc (12)

  • Reference: Zinc and depression. An update.

    Published On: November 1, 2005

    Authors: Nowak G, Szewczyk B, Pilc A PMID: 16382189 Abstract Unsatisfactory clinical efficacy and a variety of adverse effects of current antidepressant drugs have incited search for better therapy. Zinc, an antagonist of the glutamate/N-methyl-D-aspartate (NMDA) receptor, exhibits antidepressant-like activity in rodent tests/models of depression. Similarly to antidepressants, zinc induces brain derived neurotrophic factor (BDNF) [...]

    Categories: I-RECOVER Post-Vaccine

    Tags: Antidepressants, Depression, Mental Health, Zinc